Fluzone High-Dose is an influenza vaccine made by Sanofi Pasteur that contains four times the antigen found in standard flu shots. It’s designed specifically for adults 65 and older, whose immune systems typically produce a weaker response to regular vaccines. Each dose delivers 240 micrograms of hemagglutinin (the protein your immune system uses to recognize and fight influenza), compared to the 60 micrograms in a standard-dose vaccine.
Why Older Adults Need a Stronger Vaccine
Starting around age 50, the immune system gradually loses some of its ability to mount a strong defense against infections. This process, known as immunosenescence, means that when an older adult gets a standard flu shot, their body may not produce enough antibodies to be fully protected. The result is a gap between getting vaccinated and actually being shielded from the virus.
Older adults also tend to have higher levels of chronic, low-grade inflammation throughout their bodies. This combination of a weaker immune response and persistent inflammation makes people over 65 more susceptible to serious flu complications, including pneumonia and hospitalization. Fluzone High-Dose closes that gap by flooding the immune system with more of the viral protein it needs to learn from, essentially giving the body a louder signal to respond to.
How Much More Effective It Is
A large randomized trial published in the New England Journal of Medicine found that the high-dose vaccine was 24% more effective at preventing flu in adults 65 and older compared to a standard-dose vaccine. That’s not just fewer mild illnesses. A meta-analysis of randomized trial data found that the high-dose vaccine reduced hospitalizations for pneumonia and influenza by 23.5% relative to standard-dose shots. It also reduced all-cause hospitalizations, meaning fewer ER visits and hospital stays across the board during flu season.
These are meaningful numbers for a population where a flu hospitalization can trigger a cascade of complications, from dehydration and secondary infections to loss of independence.
What the CDC Recommends
The CDC’s Advisory Committee on Immunization Practices (ACIP) doesn’t just approve Fluzone High-Dose for seniors. It preferentially recommends it, along with two other enhanced options: the recombinant vaccine (Flublok) and the adjuvanted vaccine (Fluad). All three are considered superior to standard-dose flu shots for this age group, though the high-dose vaccine has the most supporting data.
If none of these three preferred vaccines is available when you show up for your shot, the CDC advises getting whatever age-appropriate flu vaccine is on hand rather than skipping the season entirely. A standard-dose vaccine still offers meaningful protection.
What’s in the Current Formulation
For the 2025-2026 flu season, Fluzone High-Dose is a trivalent vaccine, meaning it protects against three influenza strains:
- Influenza A (H1N1): derived from A/Victoria/4897/2022
- Influenza A (H3N2): derived from A/Croatia/10136RV/2023
- Influenza B (Victoria lineage): derived from B/Michigan/01/2021
Previous seasons used a quadrivalent version covering four strains, but the formulation shifts each year based on which viruses are circulating globally. Each of the viral strains is grown separately, purified, split apart (so the vaccine contains no live virus), and then combined into a single shot.
Side Effects Compared to Standard Flu Shots
Because Fluzone High-Dose delivers four times the antigen, it tends to produce slightly more noticeable side effects at the injection site. You’re more likely to experience redness, swelling, or soreness in your arm compared to a regular flu shot. Some people also report fatigue, headache, or mild muscle aches in the day or two following vaccination. These reactions are signs your immune system is responding to the higher dose, and they typically resolve on their own within a few days.
Serious adverse reactions are rare and occur at similar rates to standard-dose vaccines. The trade-off of a sore arm for significantly better flu protection is one most infectious disease experts consider well worth it for this age group.
Cost and Medicare Coverage
Medicare Part B covers one seasonal flu shot per year, including high-dose formulations. If your healthcare provider accepts Medicare assignment, you pay nothing out of pocket. This applies whether you get your shot at a doctor’s office, pharmacy, or clinic. If you’re enrolled in a Medicare Advantage plan, check with your plan directly, as coverage details can vary by network.
For those under 65 with private insurance, Fluzone High-Dose is not indicated or covered, since it’s approved exclusively for the 65-and-older population. Most private insurers cover standard-dose flu vaccines at no cost under preventive care benefits.